ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

UH

University Hospital Paris-Saclay at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

University Hospital Paris-Saclay brings 5 presentations to ACR Convergence 2026 in Orlando. Its program centres on Sjögren's disease, covering the effect of air pollution on symptoms and progression, the response tool used to read treatment trials, and results for nipocalimab and ianalumab. It also looks at how new therapies fit into treatment.

OrganizationACR Convergence 2026 Attendance
UH
University Hospital Paris-Saclay
Le Kremlin-Bicêtre, France
Hospitals and health systems
University hospital network serving the Paris-Saclay area.
Talk
Mon Nov 9
9:00am–9:30am
Part of Diagnosis and Management of Sjögren's Disease: Optimal Care in a New Era
Incorporating New Therapies into the Current Approach to Sjögren's Disease Treatment
W415A
Sjögren’s

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University Hospital Paris-Saclay

Tell us what you sell and we’ll find the people at University Hospital Paris-Saclay most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction